TRVN Archived Articles
Trevena (TRVN): Navigating the Challenges of the Pharmaceutical Landscape
Published on November 28, 2024
Trevena, Inc. (NASDAQ:TRVN): Exploring Strategic Alternatives for OLINVYK Amid Challenging Commercialization
Published on September 24, 2024